These results indicate that androgen receptors, while nectoneurons that innervate the BC and LA muscles in the essary, are not sufficient to confer androgen sensitivity to SNB and the IC muscle in the DLN.
ally dimorphic and sexually monomorphic subpopulaInc., Englewood, CO) dissolved in 0.9% NaCl. Except for the EAS, perineal muscles were exposed for Fluorotions of the SNB and the DLN apparently exhibit different sensitivities to gonadal androgens. For example, Gold injections either via a midline incision through the scrotum (exposing the BC, LA, and IC muscles) or whether sexually dimorphic motoneurons of the SNB and DLN survive depends on gonadal androgens in via a midline incision in the skin just rostral to the base of the penis in the peritoneum (exposing the EUS). The development (Nordeen, Nordeen, Sengelaub, and Arnold, 1985; Sengelaub and Arnold, 1989) , whereas the EAS was injected through the perianal skin without an incision. Each muscle received multiple (three to five) survival of EAS and EUS motoneurons does not, since equal numbers of EAS and EUS motoneurons are presinjections of Fluoro-Gold with the total volume received by any one muscle being 5 -10 ml. Prior to cloent in adult males and females (McKenna and Nadelhaft, 1986 ) despite the virtual absence of androgens in sure of the incision with wound clips and/or gut sutures, the injected muscle and the surrounding area developing females. Similarly, in adulthood, pudendal motoneurons show different sensitivities to gonadal anwere thoroughly rinsed with mammalian Ringer's to remove excess Fluoro-Gold that may have leaked from drogens. The mean size of motoneuronal somata for BC, LA, and IC motoneuronal groups decreases sigan injection site. After 7 or 8 days, animals were sacrificed and their tissues processed for AR ICC. nificantly after 4 weeks of castration, whereas the mean size of EAS and EUS motoneuronal somata does not Controls for nonspecific spread of Fluoro-Gold. Because the LA, BC, and IC all attach to the base of the change (Collins, Seymour, and Klugewicz, 1992) . Because only the sexually dimorphic pudendal motoneuphallus and are adjacent to one another, there were concerns about nonspecific spread of Fluoro-Gold berons respond to gonadal androgens by altering the size of their somata, the question arises as to whether only tween these muscles. Thus, the following injection strategy was chosen. For each animal, Fluoro-Gold was inthe androgen-sensitive pudendal motoneurons express androgen receptors (ARs).
jected into one target muscle for SNB motoneurons (BC, LA, or EAS) on one side and into one target muscle for The adult SNB and DLN are relatively rich in ARs. For example, data based on steroid autoradiography DLN motoneurons (IC or EUS) on the other side. If labeled motoneurons were found in both the SNB and (Breedlove and Arnold, 1983c) and more recently on AR immunocytochemistry (AR ICC) (Freeman, Padgett, the DLN on one side or were found bilaterally in either nucleus, this would indicate spread of the Fluoro-Gold and Breedlove, 1995; Jordan, Padgett, Hershey, Prins, and Arnold, 1997) suggest that most, but not all, adult from the injected muscle to neighboring muscles. In this case, the tissue would be excluded from the quantita-SNB and DLN motoneurons contain ARs. Thus, EAS and EUS motoneurons may fail to respond to androgen tive analysis. Because spread of Fluoro-Gold among targets on because they lack ARs. The present study set out to determine whether EAS and EUS motoneurons have the same side for either SNB or DLN motoneurons would not be detected by this strategy, seven experiARs by combining Fluoro-Gold retrograde labeling with AR ICC. I found that about 70% of EAS and about ments were done in which two different retrograde fluorescent labels were used. Animals received uni-90% of EUS motoneurons stain positively for ARs, suggesting that most EAS and EUS motoneurons have ARs, lateral injections of 5 -8% Fluoro-Ruby dissolved in NaCl (a 10,000 MW dextran, tetramethylrhodamine, despite the reported insensitivity of their size to adult androgens. These data suggest the possibility that aclysine fixable, Molecular Probes, Eugene, OR) into one SNB target (e.g., right BC) and Fluoro-Gold into cessory proteins act in collaboration with the AR to mediate the change in soma size induced by androgen.
another (e.g., right LA), as well as injections of Fluoro-Ruby and Fluoro-Gold into the two DLN targets (e.g., left IC and EUS) contralateral to the injected SNB targets (i.e., four muscles injected per animal).
METHODS
Evidence of double-labeled cells in the SNB or DLN would reveal unilateral spread among SNB (or DLN) Retrograde labeling. Normal adult male SpragueDawley rats obtained from Charles River ranging in targets. All other procedures were the same, including multiple small injections into each target, with body weight (BW) from 316 to 518 g (mean Å 420 g) were anesthetized with an ip injection (0.9 ml/kg BW) the total volume received by any one target being 3 -10 ml. Since Fluoro-Ruby has a slower transport rate of ketamine cocktail (containing 100 mg/ml ketamine, 20 mg/ml xyzaline, 10 mg/ml acepromazine) and their than Fluoro-Gold, with optimal retrograde labeling achieved after 3 weeks (Piehl, Arvidsson, and Cullmuscles injected with 5% Fluoro-Gold (Fluorochrome, heim, 1993) , animals that received Fluoro-Ruby and spread, then the tissue exposed to the primary antiserum was quantitatively assessed. An additional criteFluoro-Gold injections were sacrificed 3 weeks later and their tissues processed for AR ICC.
rion also had to be satisfied for Fluoro-Gold labeling in the DLN. Since IC and EUS motoneurons occupy AR ICC. At the time of sacrifice, animals were overdosed with an ip injection of pentobarbital and perpredominantly medial and lateral positions, respectively, in the DLN (Schroder, 1980;  McKenna and Nadelfused through the heart with physiological saline followed by 4% paraformaldehyde in 0. 1 M phosphate haft, 1986; Collins et al., 1992) , injections in the IC were required to yield Fluoro-Gold-labeled cells in the mebuffer (pH 7.4). The lumbar spinal cord was dissected and postfixed in the same fixative for 2 -3 hr at room dial aspect of the DLN whereas injections in the EUS were required to yield Fluoro-Gold labeling in the lattemperature and then transferred to 20% sucrose in 0.1 M phosphate buffer and refrigerated overnight. The eral aspect of the DLN. Under UV illumination, the number of Fluoro-Goldright side of the spinal cords was marked by a longitudinal slit through the right dorsal white matter, and the labeled motoneurons in the SNB and DLN was counted at 2001 (Figs. 1a, 1b, 1c, 2c, and 2d) . Transmitted light spinal cords were sectioned transversely at 50 mm on a freezing microtome. Floating tissue sections were illumination was then used at the same magnification to determine whether the nucleus of each Fluoro-Goldrinsed several times in a solution containing 0.1 M phosphate buffer (pH 7.4), 0.1% gelatin, and 0.3% Triton labeled motoneuron contained AR immunoreactivity (Figs. 1d, 1e, 1f, 2e, and 2f). The density of AR immuno-X-100 (PGT) and subjected to an AR ICC protocol detailed in Freeman et al. (1995) . In brief, tissue was staining was also qualitatively assessed by categorizing the staining in each nucleus as none, light (just detectblocked for nonspecific staining in a solution of PGT containing 10% normal goat serum and then transferred able), medium, or dark ( Fig. 2e shows the range of staining densities). The percentage of Fluoro-Gold-labeled to PGT containing 0.71 -1.056 mg/ml of PG-21 antiserum (courtesy of Gail Prins). One-third of the sectioned cells with AR-immunopositive nuclei was derived from these counts. tissue was incubated in PGT that lacked primary antiserum. After 72 hr at 4ЊC, tissue was reacted at room An analysis of variance was used to determine whether AR labeling varied significantly among the temperature using Vectastain ABC Elite kit reagents and nickel-enhanced diaminobenzidine as the chromovarious pudendal motoneuronal subpopulations. Separate one-way analyses of variance (ANOVA) were run gen. Tissue was mounted on gel-subbed slides and allowed to dry for at least 24 hr before coverslipping.
for the SNB and the DLN (Woodward, Bonett, and Brecht, 1990) . For the SNB, a one-way, three-level (corMounted tissue was rinsed, dehydrated, cleared in Hemo-de (Fisher Scientific), and coverslipped using responding to BC, LA, and EAS motoneuronal subpopulations) analysis was performed and for the DLN, a DPX (Fluka). Tissue was stored at 4ЊC in the dark until analysis.
one-way, two-level (corresponding to IC and EUS subpopulations) analysis was performed. If significant The specificity of the PG-21 antiserum and the reliability of the AR ICC method for detecting ARs in pumain effects were obtained, specific post hoc comparisons were made. Data are presented as the mean { dendal motoneurons are well established (Freeman et al., 1995; Matsumoto, Arai, and Prins, 1996; standard error of the mean (SEM). 1997). In brief, preabsorption experiments demonstrate that the PG-21 antiserum binds to a peptide sequence in spinal cord tissue that can be blocked by prior expo-
RESULTS
sure to the immunizing peptide but not to a peptide sequence further along in the AR. In addition, estimates Specificity and robustness of Fluoro-Gold labeling. Fluoro-Gold injections in perineal muscles consistently of the number of SNB and DLN motoneurons that contain AR based on PG-21 AR ICC agree well with previyielded brightly fluorescing cells in the SNB and DLN 7 -8 days later. Fluoro-Gold-labeled cells were also conous estimates based on steroid autoradiography (Breedlove and Arnold, 1983; sistently found only ipsilateral to the injection in the expected motor pool. No spinal cords were excluded Arnold, 1991).
Microscopic and statistical analyses. Control (no because of aberrant labeling. Moreover, when FluoroGold and Fluoro-Ruby were injected in different targets primary) tissue was previewed to assess the quality of Fluoro-Gold labeling. If appreciable numbers of SNB of the SNB and DLN, labeled cells were in their expected positions in the spinal cord and there was only and/or DLN motoneurons were labeled, and labeling was on the correct sides without evidence of nonspecific 1 doubled-labeled cell of 373 fluorescent cells, demon- strating the high degree of specificity of these two labels As expected, Fluoro-Gold injections in the IC resulted in fluorescent motoneurons concentrated in the medial [based on experiments which yielded ú10 Fluoro-Goldand ú10 Fluoro-Ruby-filled cells in either the SNB (n aspect of the DLN (Fig. 2a) whereas injections in the EUS resulted in fluorescent motoneurons concentrated Å 2) or the DLN (n Å 6)]. Because Fluoro-Gold is a remarkably stable fluorescent label, surviving extensive in the lateral aspect of the DLN (Fig 2b) . However, the percentage of motoneurons with AR-immunopositive tissue processing and showing very little fading during the analysis phase, Fluoro-Gold-labeled cells could be nuclei did not differ for these two pudendal subpopulations (main effect: P ú 0.05). Although the percentage easily recognized and counted and their AR-immunostaining characteristics assessed (Figs. 1 and 2) . At the of EUS motoneurons with AR-positive nuclei tended to be lower than the percentage of AR-positive IC motocompletion of the analysis, Fluoro-Gold labeling was still bright and would allow for a subsequent quantitaneurons (Fig. 3a) , this difference was not significant, nor were any differences revealed between these two tive analysis.
Of the 28 animals used in this study, tissue from 5 groups when estimates of the number of motoneurons with medium/dark AR-staining was compared (P ú animals was excluded because AR immunostaining was poor (n Å 2), the caudal extent of the SNB and 0.05, Fig. 3b) . Because of the possibility that Fluoro-Gold spread DLN was damaged (n Å 2), or there were too few Fluoro-Gold-labeled cells (n Å 1); this left 23 animals from between IC and EUS muscles could mask differences in AR expression between IC and EUS motoneurons, which data were obtained. The EAS muscle proved to be most difficult to label with Fluoro-Gold. To increase additional experiments were done that labeled IC and EUS motoneurons with different retrograde markers, the chances of injecting the EAS, 4 of the 8 animals that contributed data to the EAS group received bilateral Fluoro-Gold and Fluoro-Ruby, in the same animal. Such experiments verified the location of IC and EUS motoFluoro-Gold injections. The mean ({ SEM) percentage of AR-positive EAS motoneurons was no different for neurons in the DLN and their AR characteristics. As expected, IC and EUS motoneurons were located in animals that received unilateral (65 { 13.00) versus bilateral (73 { 9.96) injections of Fluoro-Gold.
predominantly medial and lateral parts of the DLN respectively (not shown). Moreover, quantitative analysis Occasionally, Fluoro-Gold-labeled cells were found midway in the ventral horn between the SNB and the again revealed that about the same mean percentage of IC and EUS motoneurons have AR-positive nuclei [94 DLN. This labeling may not, however, reflect nonspecific spread, since their position is consistent with the vs 91, respectively, based on n Å 6 (half of the experiments were based on Fluoro-Gold-labeled IC motoneumigratory path of SNB motoneurons in development (Sengelaub and Arnold, 1986 
DISCUSSION
neurons with AR-immunopositive nuclei varied significantly among pudendal subpopulations in the SNB To determine whether EAS and EUS motoneurons fail to enlarge in response to androgen treatment be-(main effect: P õ 0.002); 95% of both LA and BC motoneurons had AR-immunopositive nuclei, and 90% had cause they lack ARs, AR ICC was performed on spinal cord tissue in which specific pudendal motoneuronal medium or dark staining (Figs. 3a and 3b) . In contrast, only 69% of EAS motoneurons were AR-immunoposisubpopulations were retrogradely identified. As expected, virtually every motoneuron (96 -97%) within tive (Fig. 3a) , significantly less than 95% (P õ 0.002), and only 40% had medium or dark staining (P õ 0.001 the androgen-sensitive subpopulations (BC, LA, and IC) showed prominent AR immunostaining in their nucompared to 90%, Fig. 3b ). This conclusion seems particularly appropriate for EUS motoneurons since the percentage of motoneurons with AR-positive nuclei in this group was no different than that for the IC motoneurons. Thus, while IC and EUS motoneurons differ in their androgen sensitivity (Collins et al., 1992) , they present similar patterns of AR immunoreactivity. This fact is further underscored by two other observations. (a) When estimates are based on only those nuclei that show either medium or dark staining, eliminating the lightly stained nuclei, the average percentage dropped for both populations, but no difference was revealed. Since androgen-insensitive motoneurons belonging to the retrodorsolateral nucleus (RDLN) tend to show light AR staining in their nuclei (Freeman et al., 1995; Jordan et al., 1997) , it was possible that differences in staining density would be observed that correlate with androgen sensitivity and that such differences might not be reflected in the total number of AR-positive motoneurons. However, neither the number of motoneurons with AR-positive nuclei nor the density of immunoreactivity in motoneuronal nuclei revealed any difference between EUS and IC motoneurons. (b) Moreover, when additional experiments were carried out that used Fluoro-Gold and FluoroRuby to separately label EUS and IC motoneurons within the same animals, estimates of the number of EUS and IC motoneurons that had AR-immunopositive nuclei were virtually identical. Since motoneurons containing both Fluoro-Ruby and Fluoro-Gold were rare (only 1 double-labeled cell of 373 fluorescent cells), I conclude that Fluoro-Gold and Fluoro-Ruby successfully labeled specific subpopulations and that the results based exclusively on Fluoro-Gold are reliable. of this group might be accounted for by the fewer number of AR-positive cells and/or the larger proportion of AR-positive nuclei that were lightly stained. Hence, it is possible that some EAS motoneurons do indeed clei. However, a substantial number of EAS and EUS motoneurons (69 and 89%, respectively) also had AR change in size in response to androgen, but that this response was not detected at the population level bestaining in their nuclei, despite their reported morphological insensitivity to androgens (Collins et al., 1992) .
cause it was masked by the large number of nonresponding (presumably AR-negative and possibly light, The large number of AR-containing EAS and EUS motoneurons suggests that something in addition to ARs AR-positive) cells. Future experiments will address this possibility. is needed to confer androgen sensitivity.
At first glance, the results based on AR ICC for EUS toneurons that possessed nuclear ARs, suggesting that the change in soma size of SNB motoneurons is a cellmotoneurons seem to present a paradox, finding apparently equivalent AR expression in the face of reported autonomous response to androgen and that ARs within SNB motoneurons are crucial for this response. The differences in androgen sensitivity. One possible explanation is that the PG-21 antiserum failed to detect difpresent data extend this finding by indicating that while ARs may be necessary for this response, they are probaferences that might really exist in the AR complement of IC and EUS motoneurons. Another possible explanably not sufficient. Lubischer and Arnold (1995a,b) were the first to show tion for this paradox is that perhaps the androgen sensitivity of motoneurons is unrelated to whether or not a dissociation between AR expression and androgen sensitivity in SNB motoneurons. They found that SNB the motoneurons have ARs. In other words, the effect of androgens on motoneuron size might be indirect, motoneurons axotomized 14 days after birth were insensitive to androgen in adulthood. That is, the size of mediated through ARs somewhere else.
There is considerable precedence for the idea that previously axotomized SNB motoneurons was no longer influenced by adult androgens. Despite their the effect of androgens on SNB motoneurons is exerted indirectly via their target muscles (Araki, Harada, and lack of androgen sensitivity, such motoneurons express ARs (based on AR ICC) (Lubischer and Arnold, 1995b) . Kuno, 1991; Fishman and Breedlove, 1992; Popper, Ulibarri, and Mycevych, 1992; Rand and Breedlove, 1995) .
Interestingly, it was not the axotomy, per se, that prevented later androgen sensitivity, since SNB motoneuFor example, the length of SNB motoneuronal dendrites changes in response to adult androgens (Kurz et al., rons that were axotomized even a week later, on Day 21, retained their androgen sensitivity in adulthood 1986), an effect that is mediated, at least in part, by androgen action on the target muscles (Rand and (Lubischer and Arnold, 1995a) . These results suggest that target muscles do indeed play an important role Breedlove, 1995). Thus, ARs within perineal target muscles could, in theory, account for why some pudendal in conferring androgen sensitivity to SNB motoneurons and that there is a critical period for this effect. motoneuronal subpopulations are insensitive to androgen. However, preliminary evidence based on AR ICC
The idea that some actions of steroid hormones require the presence of both their cognate receptors and (n Å 3) reveals that all five target muscles contain ARimmunopositive nuclei, including EAS and EUS musaccessory protein(s) is not new (Alberts, Bray, Lewis, Raff, Roberts, and Watson, 1989) . Such factors are becles. Consequently, the androgen insensitivity of EAS and EUS motoneurons cannot be attributed to a lack of lieved to facilitate the effects of other transcription factors, such as steroid receptors, but not to exert an effect ARs in their target muscles. Although more detailed analysis may reveal differences in the AR complement on their own (Lindzey, Kumar, Grossman, Young, and Tindall, 1994) . At least two different types of accessory among the various perineal targets, recent evidence suggests that ARs located within motoneurons, and not proteins exist for steroid receptors, those that bind directly to DNA and those that bind to the hormone reelsewhere, play a crucial role in the androgen-mediated change in motoneuronal cell body size.
ceptor itself (Lindzey et al., 1994) . The role of accessory proteins as mediators of receptor activity comes primarWhile it has been unclear whether androgen acts directly or indirectly on SNB motoneurons to regulate ily from studies based on the estrogen and glucocorticoid receptors. One example is heat-shock protein (hsp) their size (conflicting results from Rand and Breedlove, 1995 and Araki et al., 1991) , recent results (Watson, , which binds to the estrogen receptor and is required for efficient receptor activation (Picard, Khursheed, man, and Breedlove, 1996) provide compelling evidence which suggests that androgen probably acts diGarabedian, Fortin, Lindquist, and Yamamoto, 1990; Landel, Kushner, and Greene, 1994) . However, there is rectly on SNB motoneurons to control soma size. Watson and colleagues examined neonatally androgenized clear evidence that some androgen effects are mediated by interactions of its receptor and one or more accessory adult female rats which carried a defective copy of the AR on one X chromosome. Such animals are functionproteins. In the case of the androgen-regulated sex-limited protein gene, such an accessory protein(s) seems ally mosaic for androgen sensitivity. Using such animals, these investigators find that only SNB motoneunormally to reside in the nucleus and to enhance hormone function by binding directly to specific stretches rons that express functional ARs, judged on the basis of AR immunostaining in their nuclei, change in cell of DNA that flank androgen response elements (Adler, Schellar, and Robins, 1993; Scarlett and Robins, 1995) . body size in response to adult androgens. Within the same animal, SNB motoneurons that lacked nuclear Although some putative accessory proteins have been identified (reviewed by Horwitz, Jackson, Bain, Richer, ARs had smaller somata than the neighboring SNB mo-Takimoto, and Tung, 1996; e.g., Kupfer, Wilson, and to be insensitive to androgen (Collins et al., 1992) . On the other hand, the high prevalence of AR-containing French, 1994; Cavailles, Dauvois, L'Horset, Lopez, Hoare, Kushner, and Parker, 1995; Hong, Kohli, Tri- EUS motoneurons indicates that there are factors in addition to AR expression that determine whether androvedi, Johnson, and Stallcup, 1996; McInerney, Tsai, O'Malley, and Katzenellenbogen, 1996; Smith, Onate, gen in adulthood can regulate the size of pudendal motoneurons. Tsai, and O'Malley, 1996) , there is considerable work to be done in determining the identity of such collaborators in a given hormone response in vivo and in understanding their role generally in steroid hormone ac-ACKNOWLEDGMENTS tion.
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subpopulation may be spuriously high due to the contaminating effects of nonspecific labeling of LA and BC motoneurons in some experiments. There are several
